Valuation: Silva Pharmaceuticals Limited

Market Cap 2.13B 17.29M 15.21M 14.38M 13.04M 24.5M 1.66B 24.64M 172M 66.5M 847M 64.92M 63.51M 2.72B P/E 2024
-30.3x
P/E 2025 -11x
Enterprise Value 2.06B 16.71M 14.7M 13.9M 12.61M 23.68M 1.6B 23.81M 166M 64.27M 819M 62.75M 61.39M 2.63B EV / Sales 2024
3.13x
EV / Sales 2025 3.62x
Free-Float
-
Yield 2024
0.7%
Yield 2025 -
1 day-1.57%
1 week-6.02%
Current month-6.02%
1 month-6.72%
3 months-7.41%
6 months+23.76%
Current year+32.98%
1 week 12.4
Extreme 12.4
13.7
1 month 11.8
Extreme 11.8
13.9
Current year 8.8
Extreme 8.8
18
1 year 7.6
Extreme 7.6
18
3 years 7.6
Extreme 7.6
21.6
5 years 7.6
Extreme 7.6
28.6
10 years 7.6
Extreme 7.6
37.9
Manager TitleAgeSince
Chief Executive Officer 52 2024-11-30
Director of Finance/CFO - -
Compliance Officer 49 -
Director TitleAgeSince
Chairman 48 2001-04-23
Director/Board Member 42 2001-04-23
Director/Board Member 41 2011-04-23
Change 5-day change 1-year change 3-year change Capi.($)
-1.57%-6.02%0.00%-42.13% 14.09M
+0.11%+2.76%+63.52%+115.51% 1,055B
+0.27%+0.73%+51.33%+73.10% 654B
+0.73%+0.88%+20.70%+73.89% 467B
-1.36%-0.39%+40.20%+41.03% 348B
+1.34%+5.47%+23.37%+31.30% 275B
-0.48%-0.06%+13.56%+12.36% 258B
+0.85%+8.42%+53.17%+55.45% 224B
+0.85%+1.40%+35.78%+101.47% 187B
-0.30%-10.41%-27.62%-61.04% 171B
Average +0.15%+0.13%+27.40%+40.09% 363.84B
Weighted average by Cap. +0.28%+1.32%+40.69%+69.05%

Financials

2024 2025
Net sales 600M 4.87M 4.28M 4.05M 3.67M 6.9M 467M 6.94M 48.49M 18.73M 239M 18.28M 17.89M 766M 384M 3.12M 2.74M 2.59M 2.35M 4.41M 299M 4.44M 31.02M 11.98M 153M 11.7M 11.44M 490M
Net income -64.48M -524K -461K -435K -395K -742K -50.26M -746K -5.21M -2.01M -25.65M -1.97M -1.92M -82.42M -133M -1.08M -949K -898K -814K -1.53M -104M -1.54M -10.75M -4.15M -52.88M -4.05M -3.97M -170M
Net Debt -75.17M -610K -537K -508K -460K -865K -58.59M -870K -6.08M -2.35M -29.9M -2.29M -2.24M -96.07M -71.21M -578K -509K -481K -436K -819K -55.5M -824K -5.76M -2.22M -28.32M -2.17M -2.12M -91.01M
Logo Silva Pharmaceuticals Limited
Silva Pharmaceuticals Ltd. is a Bangladesh-based pharmaceuticals company. The Company is engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of Antibiotics, Analgesics, Anti-diabetics, Narcotics, Anti-pyretic, Anti-inflammatory Drugs, Anti-ulcerants, Antiemetic, Gastroprokinetic, Anti histamine, Anti-spasmodic expectorants, Vitamins, and Minerals medicines which is selling mainly in local market. The Company produces approximately 187 generic medicines. Its products include tablets, capsules, liquids, and dry syrup. The Company’s products include Actisal, Alvolex, Atechlor, Ambosil, Cipronil, Esosil, Duet, Esypan, Feosil-Z, Glicasil, Itranox, Multitonic, Multi Gold, Lirel, Omesil, Metlife, Probac, RT-150, Silox, Simox, Xinoplex, Valpress, Vistasil M, Vasopin Plus, Zoxanid, and others.
Employees
678
Date Price Change Volume
26-09-27 BDT 12.50 -1.57% 295,491
26-09-27 BDT 12.70 -3.05% 231,254
26-09-24 BDT 13.10 -2.24% 436,952
26-09-23 BDT 13.40 +1.52% 561,182
26-09-22 BDT 13.20 -1.49% 681,900
  1. Stock Market
  2. Stocks
  3. SILVAPHL Stock